Lv31
250 积分 2025-08-07 加入
基础胰岛素周制剂依柯胰岛素治疗2型糖尿病临床应用专家指导建议
10小时前
已完结
Mora P, Aroda VR, Asong M, Blüher M, Heftdal LD, Carlander AF, Vilsen LN, Rosenstock J. Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial
17天前
已关闭
Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial
20天前
已完结
Nutritional, functional, and psychological considerations for incretin-based therapies in adults-an EASO, EFAD, and ECPO Consensus Statement
3个月前
已关闭
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once-weekly basal insulin, in healthy participants: A randomized trial. Diabetes Obes Metab
3个月前
已完结
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4 , a novel once‐weekly basal insulin, in healthy participants: A randomized trial
9个月前
已关闭
Switching to once‑weekly insulin icodec versus once‑daily insulin degludec in individuals with basal insulin‑treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat‑to‑target trial
10个月前
已关闭
Once‑weekly insulin Icodec with dosing guide App versus once‑daily basal insulin analogues in insulin‑naive type 2 diabetes(ONWARDS 5): a randomized trial
10个月前
已完结
Once‑weekly insulin icodec vs once‑daily insulin degludec in adults with insulin‑naive type 2 diabetes: the ONWARDS 3 randomized clinical trial
10个月前
已完结
Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes Lovshin, Julie A. Canadian Journal of Diabetes, Volume 41, Issue 5, 524 - 535
1年前
已完结
皖公网安备34019202002308
